What is AVOMD?
AVOMD operates at the intersection of healthcare and technology, providing a sophisticated platform designed to streamline clinical decision-making. By enabling provider organizations to digitize their clinical content, AVOMD ensures that up-to-date guidelines are instantly accessible to healthcare professionals. The platform's effectiveness is demonstrated through trials and live deployments, which have shown a marked increase in the usability and adoption of clinical guidelines. Founded by a team of physicians and informaticians from prestigious institutions like Harvard, Yale, and Mount Sinai, AVOMD's strategic partnerships include Children's Minnesota, PM Pediatrics, and Samsung Medical Center, underscoring its credibility and market traction in the health tech sector.
How much funding has AVOMD raised?
AVOMD has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2023): $5M with participation from Las Olas, AlleyCorp companies, Epsilon Health Solutions, and Medmountain Ventures
Key Investors in AVOMD
Las Olas
Las Olas appears to be a diversified investment entity with a background in commercial real estate and hospitality, indicating a potential interest in stable, long-term ventures or companies with strong operational foundations.
AlleyCorp companies
AlleyCorp is a venture firm focused on building and investing in transformative companies across enterprise tech, healthcare, and deep tech, suggesting a strategic alignment with AVOMD's innovative healthcare technology.
Medmountain Ventures
MedMountain Ventures specializes in early-stage healthcare companies, particularly those with innovative technologies, indicating a strong focus on the health tech sector and a capacity to support AVOMD's growth trajectory.
What's next for AVOMD?
With the recent major strategic investment, AVOMD is poised for significant expansion and further development of its innovative clinical decision support tools. The substantial capital injection, totaling $5M, will likely fuel advancements in its platform's capabilities, including deeper EHR integrations and broader market penetration. The company's focus on improving clinical guideline usability positions it to address critical needs in healthcare delivery, potentially leading to improved patient outcomes and operational efficiencies for provider organizations. Future growth may involve expanding its partner network and enhancing its AI-driven decision support features.
See full AVOMD company page
